A detailed history of Palisades Investment Partners, LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Palisades Investment Partners, LLC holds 15,919 shares of MEDP stock, worth $5.42 Million. This represents 2.23% of its overall portfolio holdings.

Number of Shares
15,919
Previous 14,581 9.18%
Holding current value
$5.42 Million
Previous $4.87 Billion 8.67%
% of portfolio
2.23%
Previous 2.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 18, 2025

BUY
$308.93 - $363.58 $413,348 - $486,470
1,338 Added 9.18%
15,919 $5.29 Billion
Q3 2024

Feb 18, 2025

BUY
$320.58 - $457.29 $284,995 - $406,530
889 Added 6.49%
14,581 $4.87 Billion
Q2 2024

Feb 18, 2025

BUY
$372.0 - $424.34 $5.09 Million - $5.81 Million
13,692 New
13,692 $5.64 Billion

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.6B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Palisades Investment Partners, LLC Portfolio

Follow Palisades Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisades Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisades Investment Partners, LLC with notifications on news.